Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes

S W Shen, G M Reaven, J W Farquhar, S W Shen, G M Reaven, J W Farquhar

Abstract

A technique was devised for a more accurate measurement than has been heretofore possible of one of the factors responsible for hyperglycemia in the complex syndrome of diabetes. This factor is termed impedance and represents the tissues' insensitivity or resistance to insulin-mediated glucose uptake. It was measured by use of steady-state exogenous insulin and glucose infusions during a period of pharmacological suppression of endogenous insulin secretion. Endogenous new glucose production was also inhibited. Impedance as calculated is a direct function of steady-state glucose concentrations, since exogenous insulin concentrations were similar in all studies. Two groups of normal weight subjects were studied. One had maturity onset latent diabetes, and the other (matched for age, weight, and per cent adiposity) was normal. Impedance was closely reproducible in the same individual and remained relatively constant during prolonged infusions. The diabetics had average infusion glucose concentrations (and thus impedance) 68% higher than the normal group, and it is of note that their previously measured glucose intolerance differed by a similar degree; that is, the diabetic's intolerance (as defined by mean weighted plasma glucose response after oral glucose) was 52% greater than that of the normal individuals.

References

    1. Diabetes. 1968 Jan;17(1):27-32
    1. Am J Physiol. 1965 Feb;208:301-6
    1. N Engl J Med. 1967 Feb 9;276(6):314-9
    1. Diabetes. 1969 Jan;18(1):38-43
    1. J Clin Invest. 1967 Nov;46(11):1756-67
    1. Ann N Y Acad Sci. 1965 Oct 8;131(1):357-73
    1. J Clin Invest. 1960 Jul;39:1157-75
    1. Metabolism. 1965 Oct;14(10):1059-70
    1. Diabetes. 1966 Dec;15(12):867-74
    1. Metabolism. 1967 Nov;16(11):1010-5
    1. Am J Physiol. 1956 Sep;187(1):15-24
    1. J Biol Chem. 1961 Feb;236:253-61
    1. J Chronic Dis. 1965 Dec;18(12):1279-91
    1. J Clin Invest. 1961 Sep;40:1706-18
    1. Diabetes. 1968 May;17(5):261-9
    1. Diabetes. 1967 Mar;16(3):145-9
    1. Am J Physiol. 1959 Feb;196(2):245-52
    1. Diabetes. 1968 Jan;17(1):17-26
    1. Biochem J. 1963 Jul;88:137-46
    1. Am J Med. 1966 May;40(5):676-90
    1. Arch Intern Med. 1968 Jul;122(1):6-9
    1. J Biol Chem. 1951 Feb;188(2):531-43
    1. J Biol Chem. 1965 Aug;240:3237-44
    1. J Clin Invest. 1966 Oct;45(10):1648-56
    1. J Clin Invest. 1967 Mar;46(3):323-35
    1. Lancet. 1968 Jun 22;1(7556):1353-5
    1. Diabetes. 1969 May;18(5):273-9
    1. Diabetes. 1968 Nov;17(11):684-92
    1. J Clin Invest. 1967 Jan;46(1):86-94
    1. Lancet. 1968 Jun 15;1(7555):1285-6
    1. Life Sci. 1964 Mar;3:243-9
    1. Diabetes. 1967 Sep;16(9):615-27
    1. Ann N Y Acad Sci. 1959 Sep 25;82:208-18
    1. J Chronic Dis. 1965 Dec;18(12):1291-307
    1. J Gen Physiol. 1960 Sep;44:87-103
    1. J Clin Invest. 1967 Oct;46(10):1549-57

Source: PubMed

3
Subskrybuj